4//SEC Filing
Cha Albert 4
Accession 0001209191-23-049268
CIK 0001348911other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:29 PM ET
Size
12.9 KB
Accession
0001209191-23-049268
Insider Transaction Report
Form 4
CHA ALBERT
Director
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2023-09-11−6,000→ 0 totalExercise: $6.71Exp: 2027-09-27→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2023-09-11$7.88/sh+12,000$94,560→ 18,000 total - Exercise/Conversion
Common Stock
2023-09-11$6.71/sh+6,000$40,260→ 6,000 total - Sale
Common Stock
2023-09-11$10.50/sh−18,000$189,050→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-09-11−12,000→ 0 totalExercise: $7.88Exp: 2027-03-22→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.38 to $10.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]The option is fully vested.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001397906
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:29 PM ET
- Size
- 12.9 KB